Labcyte Closes $5.3M in Financing | GenomeWeb

NEW YORK (GenomeWeb News) – Labcyte has reeled in $5.3 million in Series D financing, which it plans to use to expand its acoustic low-volume liquid handling systems, the company said on Tuesday.

The new funding included backing from new investor GE Ventures' Heatlhymagination fund, and current investors, including Abingworth, Alloy Ventures, Cross Atlantic Partners, Delphi Ventures, H&Q Healthcare Investors, and H&Q Life Sciences Investors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."